Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Assets (2016 - 2025)

OptimizeRx (OPRX) has disclosed Current Assets for 16 consecutive years, with $64.7 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 19.91% to $64.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.7 million through Dec 2025, up 19.91% year-over-year, with the annual reading at $64.7 million for FY2025, 19.91% up from the prior year.
  • Current Assets hit $64.7 million in Q4 2025 for OptimizeRx, up from $56.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $115.1 million in Q4 2021 to a low of $46.0 million in Q2 2024.
  • Historically, Current Assets has averaged $79.7 million across 5 years, with a median of $86.2 million in 2023.
  • Biggest five-year swings in Current Assets: surged 297.94% in 2021 and later plummeted 49.57% in 2024.
  • Year by year, Current Assets stood at $115.1 million in 2021, then dropped by 14.37% to $98.6 million in 2022, then tumbled by 44.88% to $54.3 million in 2023, then decreased by 0.66% to $54.0 million in 2024, then rose by 19.91% to $64.7 million in 2025.
  • Business Quant data shows Current Assets for OPRX at $64.7 million in Q4 2025, $56.3 million in Q3 2025, and $54.1 million in Q2 2025.